Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.55 |
| ▸ | CNR1 | P21554 | 4/20 | 0.55 |
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 0.55 |
| ▸ | LDHA | P00338 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18213630 | 0.93 | CNR2 (0.64) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL24332588 | 0.79 | CNR1 (0.58) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL21347741 | 0.79 | CNR1 (0.58) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL23134029 | 0.78 | CNR2 (0.62) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL21119440 | 0.77 | CNR2 (0.87) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL20764192 | 0.77 | CNR2 (0.72) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL6856463 | 0.77 | CNR2 (0.87) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL23210313 | 0.77 | CNR2 (0.87) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL18213631 | 0.77 | CNR2 (0.46) | CNR2CNR1DAGLALDHAPPARG | |
| SCHEMBL29784460 | 0.77 | CNR2 (0.87) | CNR2CNR1DAGLALDHAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115003290-A | Treatment of neisseria using cannabinoids | 博塔尼克斯药物有限公司 | 2022-09-02 | — | — | CN | disclosed |